AI

BenevolentAI, a UK company using artificial intelligence for drug development, has raised $115 million in new funding, mostly from undisclosed investors in the United States.

HIMSS UK Executive Leadership Summit panel assesses the potential of the NHS to deploy AI technologies considering the current state of its infrastructure.

The House of Lords Select Committee on Artificial Intelligence urges the NHS to digitise its 'current practices and records' by 2022 and sets out a series of recommendations to support sensible adoption of new technologies.

The FDA has granted diagnostics company IDx’s De Novo request to market its AI-based software system for the autonomous detection of diabetic retinopathy in adults who have diabetes, called IDx-DR.

Go to any healthcare conference and a speaker is bound to mention a new use of artificial intelligence.

In a new blog for BJ-HC, Eleonora Harwich, Head of Digital and Technological Innovation at Reform, looks at the application of AI in healthcare and argues the hype must not ‘cloud judgement around relevance and design’.

 In new study published in Ophthalmology,  Google AI researchers found that they could improve their AI disease detecting software by using a small subset of images adjudicated by ophthalmologists that specialize in retinal diseases.

Teams looking to AI and machine learning as a solution to their system’s problems should be reminded that the technologies are not a magic bullet, Leonard D’Avolio, cofounder of Cyft and an assistant professor at Harvard Medical School and Brigham & Women’s Hospital, said on Monday at HIMSS18.

Artificial intelligence is a hot topic right now—but whether or not it is going live up to what some are calling the new healthcare reform is still up for discussion.

A trio of presenters at HIMSS 2018 shared data from practical machine learning and AI-focused studies that demonstrate how the technologies could reduce costs and improve patients’ outcomes.